CV Therapeutics logo

CV Therapeutics

468 employees · est. 1991 · Palo Alto, United States

VS
Myogen logo

Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

est. 1996

CV Therapeutics is the older company (1991 vs 1996).

Side-by-Side Comparison

CV Therapeutics Myogen
Founded
1991 older 1996
Headquarters
Palo Alto, United States Not tracked yet
Employees
468 Not tracked yet
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Undisclosed Series D
Total Funding
Not tracked yet $187.77M
Funding Rounds
Not tracked yet 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Biopharmaceutical Company, Cardiovascular Health, Small Molecule Therapeutics, Discovery, Development, Commercialization, Clinical Expertise, Cardiovascular Disorders, Biology Of Cardiovascular Disease, Clinical Development Expertise, Novel Therapies, Licensing, Acquisition, Unmet Medical Needs
Website
cvt.com myogen.com
CV Therapeutics logo

About CV Therapeutics

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics wa...

Myogen logo

About Myogen

Myogen is a biopharmaceutical company founded in 1996, dedicated to advancing cardiovascular health with innovative small molecule therapeutics. Their slogan "Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs" reflects their mission. The company focu...

We will tell you when either one moves

BounceWatch watches CV Therapeutics and Myogen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CV Therapeutics and Myogen — by email.

Frequently Asked Questions

CV Therapeutics. Myogen — Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CV Therapeutics has raised undisclosed funding while Myogen has raised $187.77M.
CV Therapeutics and Myogen operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CV Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Myogen on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy